CMA rebuffs “ambiguous” documents claim in Prochlorperazine appeal

Advanz’s argument that unclear communications should tip in favour of the appellants challenging the UK enforcer’s Prochlorperazine cartel decision incorrectly interprets past case law on ambiguous documents, the country’s specialist competition tribunal has heard.

Unlock unlimited access to all Global Competition Review content